Clin2
NCT05889585Possibly a fitRecruiting

Life after germ cell cancer treatment side effects study

Germ Cell Tumor

Part of Cancer clinical trials.

This study looks at long-term health problems and quality of life in people who survived germ cell tumors after strong chemotherapy with a stem cell transplant or other standard treatments. It may help doctors understand which late side effects are most common and how to better support survivors.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
180 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You were diagnosed with a germ cell tumor at age 18 or older
  • You were treated at Gustave Roussy between 1990 and 2015
  • You are considered “long-term,” meaning no relapse for at least 3 years in certain situations
  • Your treatment history fits one of these paths: relapse treated with high-dose chemo plus your own stem cells; or orchiectomy only with 3+ years relapse-free; or certain metastatic cases with first-line cisplatin-based chemo (and surgery if needed)
  • You can follow the study steps and complete questionnaires or visits

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05564026Recruiting
Study of DNA patterns in childhood germ cell tumors

This study looks at “molecular” (DNA-related) features of germ cell tumors in children and teens. It also follows patients over time, which can help researchers understand tumor patterns and improve future care.

Minneapolis, Minnesota
NCT03067181Recruiting· Phase 3
Active surveillance and chemotherapy for germ cell tumors

This study looks at how to manage germ cell tumors in children and young adults using careful monitoring for some patients and chemotherapy for others. It aims to see whether these approaches can control the cancer while avoiding unnecessary treatment when possible.

Birmingham, Alabama
NCT06418789Recruiting· Phase 2
High-dose chemo for relapsed germ cell tumors

This trial tests a second-line high-dose chemotherapy for germ cell tumors that have come back after initial treatment. It may be an option for patients whose cancer progressed after 3–4 cycles of standard platinum-based chemo.

Saint Petersburg, Russian Federation
NCT07471425Not yet recruiting
Tracking quality of life in advanced neuroendocrine tumors

This study follows people with advanced neuroendocrine tumors (NETs) that cannot be removed by surgery or have spread. Its goal is to see how long patients can live without having serious side effects from treatment, so doctors can better understand which treatments are worth the risks.

Caen
NCT05670938Recruiting
Follow-up after testicular cancer surgery and chemotherapy

This study looks at how people should be followed after treatment for testicular cancer (surgery and, for some, chemotherapy). It may help improve follow-up plans while keeping an eye out for cancer coming back.

Rotterdam, South Holland
NCT05124964Recruiting
Quality of life study for newly diagnosed brain germ cell tumors

This study looks at how life quality changes in children and young adults after a new diagnosis of a brain germ cell tumor. It may help doctors understand which supports improve day-to-day well-being.

Beijing

Hear when a new Germ Cell Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.